Navigation Links
Oxford University Press launches Evolution, Medicine, and Public Health
Date:7/5/2012

Oxford University Press (OUP) and the Evolution, Medicine, and Public Health Foundation are pleased to announce the launch of the open access journal Evolution, Medicine, and Public Health (EMPH).

EMPH publishes original, rigorous applications of evolutionary biology to problems in medicine and public health, and research that advances basic evolutionary biology by studying issues that arise in the medical sciences. Knowledge will flow in both directions, with emphasis on work with the potential to reduce suffering and save lives. Because evolutionary biology is a basic science that reaches across many disciplines, EMPH is open to contributions on a broad range of topics.

The President of the Foundation, Randolph Nesse, said: "Evolutionary biology is a science whose applications in medicine and public health are finally being recognized. Articles published in EMPH will bring new recognition to these applications and to studies of disease that advance basic science. The Foundation is grateful to the distinguished evolutionary biologist Professor Stephen Stearns of Yale University for agreeing to lead the journal as Editor-in Chief. He has recruited eighty-nine of the most respected scholars in their fields to serve as Associate Editors; they include, as Senior Editors, David Haig (Harvard University), Carlo Maley (University of California, San Francisco), Angela McLean (University of Oxford), Andrew Read (Pennsylvania State University), and Gregory Wray (Duke University). The Foundation looks forward to working with Oxford University Press and appreciates its willingness to make EMPH fully open access and to provide for publication by authors with limited funding. The launch of EMPH marks the coming of age of evolutionary medicine. Its content will transform our understanding of the body and disease in ways that improve human health."

Cathy Kennedy, Senior Publisher, Life Sciences, at OUP said: "We are extremely proud and excited to announce the EMPH launch. We see the new journal as a great tool to promote dialogue between the disciplines of evolutionary biology and medicine, acting as a catalyst for research that will make a serious impact on humankind. Professor Stearns has gathered together a first-class team of editors who will help to ensure that the new journal is of the very highest quality."

The first papers in Evolution, Medicine, and Public Health will be published by OUP in late 2012. The journal is now open for contributions on a broad range of topics and is designed to be of interest and accessible across a broad spectrum of biological and medical disciplines. No author's fees will apply in the first year, and arrangements are in place for on-going publication of articles by authors with limited funding. Visit the website for more information, submission guidelines, and to sign up to receive tables of contents by email or RSS: www.emph.oxfordjournals.org


'/>"/>

Contact: Lizzie Shannon-Little
lizzie.shannonlittle@oup.com
44-186-535-3043
Oxford University Press
Source:Eurekalert

Related medicine news :

1. Wayne State University researcher seeks to understand link between obesity, flu severity
2. New £340,000 investment into asthma and allergy research at University of Leicester
3. University of Nevada School of Medicine researcher reviews muscular dystrophy therapies
4. Arizona State University secures defense contract
5. Wayne State University researcher examines proteins role in diabetic retinopathy
6. University Hospitals Case Medical Center experts present at ASCO Annual Meeting
7. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
8. McMaster University researchers discover drug destroys human cancer stem cells but not healthy ones
9. University studies and career expectations of medical students
10. University of Minnesota startup to treat challenging bacterial infection
11. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: